Involvement of protease inhibitors in staphylokinase-induced fibrin-specific fibrinolysis

Biol Pharm Bull. 1994 Dec;17(12):1595-8. doi: 10.1248/bpb.17.1595.

Abstract

We compared the fibrinolytic properties of recombinant staphylokinase (SAK), a fibrin-specific plasminogen activator, with those of streptokinase and tissue-type plasminogen activator (t-PA) by means of the amidolytic method. We also investigated the involvement of alpha 2-macroglobulin, C1-inactivator and alpha 1-antitrypsin in SAK-induced fibrin-specific fibrinolysis. Both SAK and t-PA activated plasminogen efficiently in the presence of fibrin in human plasma. Although t-PA activated plasminogen dependently on fibrin in the reconstituted plasma system, SAK activated plasminogen independently of fibrin without alpha 2-plasmin inhibitor (alpha 2-antiplasmin, alpha 2-PI). These findings suggest that fibrin and alpha 2-PI play important roles in plasminogen activation by SAK but not by t-PA. Furthermore, protease inhibitors such as alpha 2-PI, alpha 2-macroglobulin, C1-inactivator and alpha 1-antitrypsin inhibited plasminogen activation by SAK and the inhibitory actions of these protease inhibitors disappeared in the presence of fibrin. This shows that alpha 2-macroglobulin, C1-inactivator and alpha 1-antitrypsin, other than alpha 2-PI, contribute to the fibrin-specificity of SAK.

Publication types

  • Comparative Study

MeSH terms

  • Amino Acid Sequence
  • Chromatography, Ion Exchange
  • Fibrin / metabolism*
  • Fibrinolysis / physiology*
  • Humans
  • Metalloendopeptidases / metabolism*
  • Molecular Sequence Data
  • Molecular Weight
  • Protease Inhibitors / metabolism*
  • Recombinant Proteins / metabolism
  • Tissue Plasminogen Activator / metabolism

Substances

  • Protease Inhibitors
  • Recombinant Proteins
  • Fibrin
  • Tissue Plasminogen Activator
  • Metalloendopeptidases
  • auR protein, Staphylococcus aureus